Hôpital Privé Jean Mermoz
Hôpital Privé Jean Mermoz
Lyon, France28 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 3 | 2026-10-05 | NCT06982521 | |
| Long-term Clinical and Anatomical Evaluation of Edge-to-edge Repair of Large to Very Large Rotator Cuff Tears | Rotator Cuff Disorders | Not yet recruiting | Not applicable | 2026-09-24 | NCT07838922 | |
| The Clinical and Ultrasound Outcomes of Double-row "Knotless" Rotator Cuff Repairs Using the Montgolfier Technique | Double Raw Repair; Rotator Cuff | Not yet recruiting | Not applicable | 2026-09-18 | NCT07828366 | |
| Assessment of Posterior Subluxation of the Humeral Head Using Biplanar Imaging in the Upright Position in Patients Scheduled for Total Shoulder Arthroplasty | Shoulder Arthroplasty | Not yet recruiting | Not applicable | 2026-09-17 | NCT07819149 | |
| Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients) | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Not applicable | 2026-09-11 | NCT01817192 | |
| Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 3 | 2026-09-09 | NCT05633654 | |
| Efficacy and Safety of Intravenous Lidocaine Versus Placebo in Patients Receiving Morphine-rachi Analgesia | Digestive System Diseases | Not yet recruiting | Phase 3 | 2026-08-25 | NCT07076641 | |
| Assesment of Epidural Platelet-Rich Plasma (PRP) Injection During Uniportal Endoscopic Lumbar Disc Herniation Excision on Residual Neuropathies | Hernia, Intervertebral Disc Displacement, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, bone disorder, musculoskeletal system disorder, vertebral column disorder | Not yet recruiting | Not applicable | 2026-08-20 | NCT07770750 | |
| Superb Microvascular Imaging (SMI) and Two-Dimensional Endoscopic Ultrasound Guided Shear Wave Elastography (2D-SWE-EUS) in Differential Diagnosis of Pancreatic Adenocarcinoma (PA) From Other Pancreatic Solid Lesions (PSLs) and Pancreatic neuroendocrinE Tumors (pNETs) Malignancy | Pancreas Adenocarcinoma (MSI-H); Pancreatic Neuroendocrine Tumors (pNET) | Recruiting | Not applicable | 2026-08-20 | NCT07274657 | |
| Microbiological Molecular Profile of the Knee Joint During Primary Reconstruction or Revision Surgery of the ACL | Anterior Cruciate Ligament Injuries, Knee Injuries, Leg Injuries, injury | Recruiting | Not applicable | 2026-08-20 | NCT07009392 | |
| Long-term Evaluation of Sports Activity in Patients Whose Ankle Was Treated by Anatomical Reconstruction or Arthroscopic Repair Following Chronic Lateral Instability | Ankle Instability | Recruiting | Not applicable | 2026-08-20 | NCT06945198 | |
| Correlation Study Between the Classification of Arthrogenic Motor Inhibition (AMI) and Clinical Assessment After ACL Rupture | Anterior Cruciate Ligament Injuries, Knee Injuries, Leg Injuries, injury | Not yet recruiting | Not applicable | 2026-08-20 | NCT06945133 | |
| Assessment of Collagen Membrane Interest in Distal Cuff Lesions Repair | Cuff Rotator Syndrome | Recruiting | Not applicable | 2026-08-20 | NCT06269965 | |
| Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas | Digestive System Diseases, Digestive System Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, metastatic malignant neoplasm, neoplasm, stomach disorder | Recruiting | Phase 3 | 2026-06-25 | NCT06346197 | |
| Assessment of SMI (Superb Microvascular Imaging) for Characterising the Endocystic Material of Papillary Intraductal Mucinous Pancreatic Tumours (PIMPT) | Papillary and Mucinous Intraductal Tumours of the Pancreas | Not yet recruiting | Not applicable | 2026-06-23 | NCT07663734 | |
| Assessment of NEURO-K-STARTS Following Primary Anterior Cruciate Ligament (ACL) Reconstruction | Anterior Cruciate Ligament Injuries, Knee Injuries, Leg Injuries, injury | Not yet recruiting | Not applicable | 2026-06-22 | NCT07659613 | |
| Assessment of Electromyographic Activity in the Quadriceps and Hamstrings of the Operated Limb Versus the Unaffected Limb in Patients Who Have Undergone ACL Surgery, With and Without Post-operative AMI - an Exploratory Study | Anterior Cruciate Ligament Injuries, Knee Injuries, Leg Injuries, injury | Not yet recruiting | Not applicable | 2026-06-22 | NCT07659561 | |
| Assessment of the Usefulness of SMI (Superb Vascular Imaging) for the Characterisation of Pancreatic Cystic Tumours (IMAKYST) | Cystadenoma, Serous, Neoplasms by Histologic Type, adenoma, cystadenoma, cystic, mucinous, and serous neoplasm, epithelial neoplasm, neoplasm | Recruiting | Not applicable | 2026-06-18 | NCT07657884 | |
| Intraoperative Analysis of Knee Kinematics During ACL Reconstruction - an Exploratory Study | Anterior Cruciate Ligament Injuries, Knee Injuries, Leg Injuries, injury | Not yet recruiting | Not applicable | 2026-06-18 | NCT07655726 | |
| Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 3 | 2026-05-26 | NCT07237256 | |
| Study on the Relative Dose Intensity of PARP Inhibitors in Real-life on a Population of Patients Over 70 Years With Advanced Ovarian Cancer | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Recruiting | Not stated | 2026-02-23 | NCT06572735 | |
| Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Nutritional and Metabolic Diseases, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, dihydropyrimidine dehydrogenase deficiency, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, intestinal disorder, metabolic disease, neoplasm, rectal disorder | Recruiting | Phase 2 | 2025-12-10 | NCT06245356 | |
| Evaluation of a New Navigation System in Computer-assisted Total Knee Arthroplasty | arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, rheumatic disorder | Active, not recruiting | Not applicable | 2025-12-03 | NCT05435690 | |
| Interest of a Highly Cross-linked Polyethylene Acetabular Component Doped With Vitamin E in Total Hip Arthroplasty of the Young and Active Subject | Hip Arthropathy | Recruiting | Not applicable | 2025-12-03 | NCT05175300 | |
| Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2025-08-20 | NCT05625087 |